Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FZ4VE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,178
Award facts
- Contract value 100% obligated
- $10,178.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,178.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on January 6, 2026, with an ultimate completion date of January 7, 2026. This non-competed delivery order was placed against AmerisourceBergen's parent company Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.99 million through December 2031. Repatha is a specialty pharmaceutical used for cholesterol management and cardiovascular disease prevention, reflecting DLA's ongoing procurement of essential medications to support military healthcare systems and veteran populations.
This delivery order represents a routine execution under the broader pharmaceutical prime vendor agreement that enables DLA to source a vast range of medications, vaccines, medical devices, and specialty pharmaceuticals on a global basis. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical supplier for federal medical procurement and maintains significant contract relationships across multiple government healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The firm fixed-price structure and rapid fulfillment timeline indicate this delivery order addresses an immediate operational need within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DR26FZ4VE?
SPE2DR26FZ4VE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FZ4VE worth?
The government has obligated $10,178 on SPE2DR26FZ4VE.
Is contract SPE2DR26FZ4VE an order under another contract?
Yes. SPE2DR26FZ4VE is a delivery order under SPE2DR25D1050, an indefinite delivery contract.
Was contract SPE2DR26FZ4VE competed?
The extent of competition for SPE2DR26FZ4VE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award